HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Self-injection anxiety training: a treatment for patients unable to self-inject injectable medications.

Abstract
Anxiety and phobia frequently prevent patients with multiple sclerosis (MS) from self-injecting their injectable disease-modifying medications. This small, randomized, controlled trial tested the efficacy of a six-session nurse-administered programme to teach self-injection to patients with MS, who, due to anxiety or phobia, were unable to self-inject their injectable medications. Participants were 30 patients with MS who were prescribed interferon beta-1a (IFNbeta-1a) administered via weekly intramuscular injection. All patients were unable to self-inject due to anxiety or phobia. Patients were randomized to either the six-session Self-Injection Anxiety Therapy (SIAT) or a control telephone support condition modelled on the support programme offered by the manufacturer of IFNbeta-1a. Four patients dropped out of SIAT while three dropped out of the control condition. Eight patients receiving SLAT compared to three control patients, were able to self-inject after six weeks of treatment. SIAT patients were significantly more likely to achieve self-injection at treatment cessation, compared to telephone control patients, in completer analyses (p =0.022), however, this only reached a trend in intent-to-treat analyses (p =0.058). These findings suggest that SIAT is a potentially valuable intervention to teach self-injection skills to injection phobic and anxious patients, and should be investigated more thoroughly in a larger clinical trial.
AuthorsDavid C Mohr, Darcy Cox, Natalia Merluzzi
JournalMultiple sclerosis (Houndmills, Basingstoke, England) (Mult Scler) Vol. 11 Issue 2 Pg. 182-5 (Apr 2005) ISSN: 1352-4585 [Print] England
PMID15794392 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Interferon-beta
  • Interferon beta-1a
Topics
  • Adjuvants, Immunologic (administration & dosage)
  • Adolescent
  • Adult
  • Anxiety (nursing, psychology)
  • Female
  • Humans
  • Injections, Intramuscular (methods, nursing, psychology)
  • Interferon beta-1a
  • Interferon-beta (administration & dosage)
  • Male
  • Middle Aged
  • Multiple Sclerosis (drug therapy, nursing, psychology)
  • Phobic Disorders (nursing, psychology)
  • Self Administration (methods, nursing, psychology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: